Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy

22 Nov 2020

Abstract excerpt

Non-small cell lung cancer (NSCLC) remains the most prevalent and one of the deadliest cancers worldwide. Despite recent success, there is still an urgent need for new therapeutic strategies. It is also becoming increasingly evident that combinatorial approaches are more effective than single modality treatments. This review proposes that the serum and glucocorticoid-inducible kinase 1 (SGK1) may represent an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Helicobacter pylori-related gastroenterology studies
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33266470
DOI: 10.3390/ph13110413

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC TherapyPMID 33266470Read ↗

SGK1 in Human Cancer: Emerging Roles and MechanismsSemantic proximity Read ↗

Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.Semantic proximity Read ↗

Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseasesSemantic proximity Read ↗

Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth.Semantic proximity Read ↗

SGK1, a Critical Regulator of Immune Modulation and Fibrosis and a Potential Therapeutic Target in Chronic Graft-Versus-Host DiseaseSemantic proximity Read ↗

Regulation of a third conserved phosphorylation site in SGK1.Semantic proximity Read ↗

Identification and Exploration of Serine Peptidase Inhibitor Kazal Type 1 (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung CancerSemantic proximity Read ↗

Sgk1, a cell survival response in neurodegenerative diseasesSemantic proximity Read ↗

Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cellsSemantic proximity Read ↗

GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapySemantic proximity Read ↗

A novel serum glucocorticoid regulated kinase 1 inhibitor improves cardiac structure and function in heart failureSemantic proximity Read ↗

Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.